These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 16455061)
41. Baroreceptor-mediated inhibition of respiration after peripheral and central administration of a 5-HT1A receptor agonist in neonatal piglets. Curran AK; Leiter JC Exp Physiol; 2007 Jul; 92(4):757-67. PubMed ID: 17392335 [TBL] [Abstract][Full Text] [Related]
42. Characterization of the serotonin1A receptor antagonist activity of WAY-100135 and spiperone. Escandon NA; Zimmermann DC; McCall RB J Pharmacol Exp Ther; 1994 Jan; 268(1):441-7. PubMed ID: 8301586 [TBL] [Abstract][Full Text] [Related]
43. Role of dorsal raphe neurons in paradoxical sleep generation in the cat: no evidence for a serotonergic mechanism. Sakai K; Crochet S Eur J Neurosci; 2001 Jan; 13(1):103-12. PubMed ID: 11135008 [TBL] [Abstract][Full Text] [Related]
44. Activation of 5-HT1A receptors in raphe pallidus inhibits leptin-evoked increases in brown adipose tissue thermogenesis. Morrison SF Am J Physiol Regul Integr Comp Physiol; 2004 May; 286(5):R832-7. PubMed ID: 14742306 [TBL] [Abstract][Full Text] [Related]
45. Blockade of 5-HT(1A) receptors in the phrenic nucleus of the rat attenuated raphe induced activation of the phrenic nerve activity. Pecotic R; Dogas Z; Valic Z; Valic M J Physiol Pharmacol; 2009 Sep; 60(3):167-72. PubMed ID: 19826196 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of bladder activity by 5-hydroxytryptamine1 serotonin receptor agonists in cats with chronic spinal cord injury. Gu B; Olejar KJ; Reiter JP; Thor KB; Dolber PC J Pharmacol Exp Ther; 2004 Sep; 310(3):1266-72. PubMed ID: 15152026 [TBL] [Abstract][Full Text] [Related]
47. Activation of slowly conducting medullary raphe-spinal neurons, including serotonergic neurons, increases cutaneous sympathetic vasomotor discharge in rabbit. Ootsuka Y; Blessing WW Am J Physiol Regul Integr Comp Physiol; 2005 Apr; 288(4):R909-18. PubMed ID: 15550616 [TBL] [Abstract][Full Text] [Related]
48. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain. Assié MB; Ravailhe V; Faucillon V; Newman-Tancredi A J Pharmacol Exp Ther; 2005 Oct; 315(1):265-72. PubMed ID: 15987834 [TBL] [Abstract][Full Text] [Related]
49. The 5HT1A receptor agonist, 8-OH-DPAT, protects neurons and reduces astroglial reaction after ischemic damage caused by cortical devascularization. Ramos AJ; Rubio MD; Defagot C; Hischberg L; Villar MJ; Brusco A Brain Res; 2004 Dec; 1030(2):201-20. PubMed ID: 15571670 [TBL] [Abstract][Full Text] [Related]
50. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system. Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803 [TBL] [Abstract][Full Text] [Related]
51. Activation of 5-HT(1A) receptors attenuates tachycardia induced by restraint stress in rats. Ngampramuan S; Baumert M; Beig MI; Kotchabhakdi N; Nalivaiko E Am J Physiol Regul Integr Comp Physiol; 2008 Jan; 294(1):R132-41. PubMed ID: 17959705 [TBL] [Abstract][Full Text] [Related]
52. Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications. Ba M; Kong M; Ma G; Yang H; Lu G; Chen S; Liu Z Brain Res; 2007 Jan; 1127(1):177-84. PubMed ID: 17113046 [TBL] [Abstract][Full Text] [Related]
53. The effects of 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) on food intake in non-deprived C57BL6 mice. Ebenezer IS; Surujbally A Eur J Pharmacol; 2007 Mar; 559(2-3):184-8. PubMed ID: 17300778 [TBL] [Abstract][Full Text] [Related]
54. Effects of 8-OH-DPAT on hippocampal NADH fluorescence in vivo in anaesthetized rats. Rex A; Fink H J Neurosci Res; 2006 Mar; 83(4):551-6. PubMed ID: 16435395 [TBL] [Abstract][Full Text] [Related]
55. Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology. Cussac D; Palmier C; Finana F; De Vries L; Tardif S; Léger C; Bernois S; Heusler P J Pharmacol Exp Ther; 2009 Oct; 331(1):222-33. PubMed ID: 19605522 [TBL] [Abstract][Full Text] [Related]
56. WAY100635 blocks the hypophagia induced by 8-OH-DPAT in the hypothalamic nuclei. Steffens SM; Beckman D; Faria MS; Marino-Neto J; Paschoalini MA Physiol Behav; 2010 Apr; 99(5):632-7. PubMed ID: 20138904 [TBL] [Abstract][Full Text] [Related]
57. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist. Piper BJ; Vu HL; Safain MG; Oliver AJ; Meyer JS J Pharmacol Exp Ther; 2006 May; 317(2):838-49. PubMed ID: 16434566 [TBL] [Abstract][Full Text] [Related]
58. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors. Hagiwara H; Fujita Y; Ishima T; Kunitachi S; Shirayama Y; Iyo M; Hashimoto K Eur Neuropsychopharmacol; 2008 Jun; 18(6):448-54. PubMed ID: 18164909 [TBL] [Abstract][Full Text] [Related]
59. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. Forster EA; Cliffe IA; Bill DJ; Dover GM; Jones D; Reilly Y; Fletcher A Eur J Pharmacol; 1995 Jul; 281(1):81-8. PubMed ID: 8566121 [TBL] [Abstract][Full Text] [Related]
60. Role of spinal 5-HT(1A) receptors in morphine analgesia and tolerance in rats. Bardin L; Colpaert FC Eur J Pain; 2004 Jun; 8(3):253-61. PubMed ID: 15109976 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]